The EULAR/ACR/PRINTO criteria, which was originally developed for patients with juvenile idiopathic arthritis, has been suggested for use in adult patients with rheumatic disease, considering that soluble IL-2 and NK-cell activity are not routinely accessible in most hospitals [11, 25]. This evidence concerns the gene IL2 and rheumatic disorder.